Explore all the latest information in acute myeloid leukemia, arranged by key congresses and meetings. Listed below are recently updated congresses and meetings.
Do older patients with FLT3 AML benefit from midostaurin plus chemotherapy?
During the 62nd ASH Annual Meeting and Exposition, the AML Hub was pleased to speak to Jorge Sierra, Hospital de la Sant...
ASH 2020: Highlights for patients with TP53-mutated AML
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the AML Hub spoke to Uwe Platzbecker, University of Leipzig...
Old and new ADCs for the treatment of ALL and AML
Since the beginning of their development in the early 1980s, a lot of progress has been made in the development of monoclonal antibodies for cancer...
How should we monitor patients on novel agents such as venetoclax?
During the 3rd Annual Meeting of the International Academy for Clinical Hematology (IACH), the AML Hub was pleased to speak to Thomas...
Single cell analysis in AML
Measurable residual disease (MRD) is a readout used to inform prognosis and treatment decisions in patients with acute myeloid leukemia (AML), and there are currently two...
Antibody immunotherapy: Current challenges and achievements
In recent years, increasing numbers of immunomodulatory antibodies have been produced with the aim of treating patients with...
The history and evolution of the role of venetoclax in the treatment of AML
Despite only being approved in the last few years, venetoclax has already become a standard of care for treating patients...
Updates from NCRI AML18 and AML 19 trials
During the 2nd National Cancer Research Institute (NCRI) acute myeloid leukemia (AML) Academy Meeting, Nigel Russell presented updated data on the ongoing...
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Hematology
European Hematology Association
European School of Haematology
European Society for Blood and Marrow Transplantation
International Academy for Clinical Hematology
International Symposium on Acute Leukemias
National Cancer Research Institute
NCRI AML Academy 2019
NCRI AML Academy 2020
ASTCT and CIBMTR TCT Meeting 2020
EHA–EBMT CAR T Meeting 2020
Society of Hematologic Oncology